Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart
Health

Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart

Bloomberg Markets Monday 17 August 2026, 08:03 UTC By Naomi Kresge 1 min read
Key Points

Health Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart. The drug helped patients with autoimmune myositis, a disease in which the immune system attacks the muscles and can quickly rob patients of their independence, Argenx said Monday. The shares climbed as much as 10%, the most in more than a year on an intraday basis.

Health Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart. The drug helped patients with autoimmune myositis, a disease in which the immune system attacks the muscles and can quickly rob patients of their independence, Argenx said Monday. The shares climbed as much as 10%, the most in more than a year on an intraday basis.
Argenx Soars (PERSON) Latest Trial Success for Autoimmune Drug Vyvgart Health Argenx Soars (ORG) Latest Trial Success for Autoimmune Drug (ORG) European (ORG) Vyvgart (ORG) Argenx (PERSON)
Originally published by Bloomberg Markets Read original →

Related Stories

NHS programme could prevent 100 kidney transplants being rejected each year

NHS programme could prevent 100 kidney transplants being rejected each year In addition to ensuring blood types match, scientists will now align white blood cells as closely as possible - Bookmark - CommentsGo to comments The NHS is introducing a "double matching" blood process for kidney transplant patients to help ensure donated organs are less likely to be rejected. In addition to ensuring blood types match, scientists will now align white blood cells as closely as possible. NHS Blood and...

The Independent UK 14m ago

Heart transplant survivor fights to keep access to anti-rejection drug

Payton Herres was 11 when she received a donated heart in 2012. Fifteen years later, at 26, she was fighting to access the anti-rejection medicine that helps keep her donor heart working, with her case eventually reaching billionaire Mark Cuban. Herres, now 26, was born with Ebstein’s anomaly, a rare congenital heart condition affecting the tricuspid valve on the right side of the heart.

Times of India 36m ago

Woman in her 50s dies after Limavady crash

Ambulance crews treated the woman at the scene but she died a short time later from her injuries, police said.

BBC Northern Ireland 43m ago

'Tent fell, barricades collapsed': Stampede-like situation at Ujjain temple leaves devotees injured

TOI News Desk / TIMESOFINDIA.COM / Updated: Aug 17, 2026, 13:47 IST Comments Share AA Text Size Small Medium Large Several devotees were reportedly injured after a stampede-like situation broke out near temple complex NEW DELHI:

Times of India 54m ago